Optimising Surgical Recovery: Pre & Post Operative Shockwave & Laser Therapy

Surgery is a pivotal biological event. Whether you are preparing for anterior cruciate ligament (ACL) reconstruction, rotator cuff repair, total knee arthroplasty, or Achilles tendon surgery, what happens in the weeks before and after your procedure has a profound impact on how completely and how quickly you recover. The tissues you bring into the operating theatre, their vascularity, collagen architecture, inflammatory state, and cellular energy reserves, shape both the quality of the surgeon’s work and the efficiency of your subsequent healing.

The field of perioperative physiotherapy recognises that both the pre-operative and post-operative periods offer active intervention opportunities that can meaningfully alter clinical trajectories. Prehabilitation, the structured preparation of the body before surgery, is now strongly supported by evidence. A 2023 systematic review and meta-analysis of 48 randomised controlled trials involving 3,570 patients undergoing orthopaedic surgery found that prehabilitation programmes significantly improved pre-operative function, health-related quality of life, and muscle strength, with these benefits extending into the post-operative recovery period (Punnoose et al., 2023).

At Movement Mechanics, two evidence-informed physical modalities sit at the forefront of our perioperative toolkit: EMS DolorClast® Extracorporeal Shockwave Therapy (ESWT) and High-Power Laser Therapy (HPLT). These are not passive symptom-management tools, they are active biological interventions that engage specific cellular and molecular pathways governing angiogenesis, collagen synthesis, mitochondrial function, and inflammatory resolution. This article outlines the physiological rationale, clinical evidence, and practical application of each modality in the pre- and post-operative orthopaedic setting.

Understanding the Modalities

EMS DolorClast® Extracorporeal Shockwave Therapy

Extracorporeal Shockwave Therapy (ESWT) delivers high-energy acoustic waves into biological tissue through a handheld applicator applied to the skin surface. The EMS DolorClast® (Electro Medical Systems, Switzerland) is the world’s most clinically validated radial shockwave device. More than 50% of all level 1 randomised controlled trials conducted with radial shockwave devices have used the DolorClast® system, with 34 of 62 RCTs listed in the PEDro clinical research database performed using this technology. Across these trials, 80% demonstrate superior clinical outcomes compared to control conditions, a level of evidential consistency unmatched in the radial shockwave field (EMS Electro Medical Systems, 2024).

Radial shockwave therapy (RSWT) generates acoustic waves pneumatically within the handpiece, which radiate outward from the applicator tip in a divergent pattern. This distinguishes it from focused ESWT, which concentrates energy at a specific tissue depth. Radial waves are particularly well-suited to superficial-to-intermediate musculoskeletal structures, tendons, muscle-tendon junctions, periosteum, bursae, and fascial layers, encompassing the most common surgical targets in orthopaedic practice.

High-Power Laser Therapy

High-Power Laser Therapy (HPLT; Class IV laser) delivers photons in the red (630–700 nm) and near-infrared (NIR; 750–1100 nm) spectrum to biological tissues at power outputs substantially greater than conventional low-level laser therapy (LLLT; Class III). Higher power outputs, typically 500 mW to 60 W depending on the device and clinical indication, enable deeper tissue penetration, reaching joint capsules, tendons, ligaments, cortical bone surfaces, and deep musculature within clinically practical treatment durations.

HPLT operates through photobiomodulation (PBM): non-thermal, photochemical interactions between specific photon wavelengths and endogenous intracellular chromophores. Unlike ablative or surgical lasers, HPLT does not destroy tissue, it stimulates biological repair cascades at the cellular and subcellular level, making it a safe and well-tolerated adjunct in the perioperative setting.

The Science: How These Modalities Work

Shockwave Therapy: Mechanotransduction and Biological Signalling

The therapeutic effects of ESWT are primarily mediated through mechanotransduction, the process by which cells convert external mechanical stimuli into intracellular biochemical signals that regulate gene expression and cellular behaviour (Wang, 2012). When acoustic waves enter tissue, the resulting mechanical deformation activates transmembrane mechanoreceptors including integrins and caveolae on the cell surface. This initiates phosphorylation of Caveolin-1 and activation of β1-Integrin signalling, with downstream engagement of the ERK1/2 and Akt pathways, key mediators of cell survival, proliferation, and regenerative gene transcription (Wang, 2012; Lo et al., 2022).

The principal downstream biological responses include:

• Angiogenesis and Neovascularisation: ESWT consistently upregulates vascular endothelial growth factor (VEGF) and endothelial nitric oxide synthase (eNOS), driving the formation of new blood vessels within treated tissue. Improved vascularity delivers oxygen, nutrients, and circulating growth factors to healing structures, a particularly critical effect in the hypovascular zones characteristic of chronic tendinopathy and degenerative joint disease (Notarnicola & Moretti, 2012; Mani-Babu et al., 2015).

• Collagen Synthesis and Tendon Remodelling: Tenocytes and fibroblasts exposed to shockwave energy upregulate Type I collagen production, the primary structural collagen of tendons and ligaments. In tendinopathic tissue, the common backdrop to many orthopaedic surgical indications, ESWT shifts the cellular environment from degenerative to regenerative, favouring organised collagen synthesis over disordered matrix accumulation (Lo et al., 2022; Mani-Babu et al., 2015).

• Osteogenesis: ESWT promotes bone healing through upregulation of bone morphogenetic protein-2 (BMP-2), osteocalcin, and VEGF in bone marrow stromal cells, enhancing differentiation along osteoprogenitor lineages. Periosteal thickening and activation of periosteal progenitor cells has also been demonstrated, with direct implications for bone tunnel healing, osteotomy consolidation, and fracture repair (Wu et al., 2023).

• Myogenesis and Muscle Regeneration: Radial shockwaves modulate the viability and gene expression of human skeletal muscle cells, upregulating Pax7, NCAM, Myf5, and MyoD, satellite cell markers and myogenic regulatory factors that govern muscle repair and regeneration. This myogenic capacity is directly relevant to preventing and reversing the peri-articular muscle atrophy that invariably accompanies orthopaedic surgery and post-operative immobilisation (PMC5889540, 2018).

• Mesenchymal Stem Cell Activation: ESWT recruits and activates mesenchymal stem cells (MSCs) in surrounding tissue. These multipotent progenitor cells can differentiate into tenocytes, osteoblasts, or chondrocytes according to local signalling cues, providing a replenishable pool of regenerative cells at the surgical site (Wang, 2012).

High-Power Laser Therapy: Photobiomodulation and Cellular Energetics

The primary mechanism of HPLT is the absorption of red and NIR photons by cytochrome c oxidase (CcO), Complex IV of the mitochondrial electron transport chain, the predominant intracellular chromophore for therapeutic wavelengths (Hamblin, 2018). CcO drives oxidative phosphorylation and is directly responsible for ATP synthesis.

In metabolically stressed, inflamed, or hypoxic tissues, conditions characteristic of chronic orthopaedic pathology and the acute post-operative environment, nitric oxide (NO) produced by inflammatory cells competitively binds to CcO. This NO-mediated inhibition suppresses the electron transport chain and reduces ATP synthesis, impairing energy-dependent cellular functions including protein synthesis, DNA repair, membrane transport, and cellular division (Hamblin, 2018). HPLT photons of the appropriate wavelength dissociate NO from CcO, restoring electron transport activity and driving a rapid increase in ATP production, a process termed ‘mitochondrial rescue.’

This photochemical event initiates a cascade of downstream biological effects:

• Accelerated Cellular Repair: With restored ATP reserves, cells execute energy-intensive repair processes, collagen synthesis, membrane restoration, enzyme production, with greater efficiency, accelerating healing across all tissue types (Hamblin, 2018).

• Anti-Inflammatory Cascade: PBM comprehensively suppresses inflammatory signalling. Documented effects include inhibition of cyclooxygenase-2 (COX-2) expression and reduction of prostaglandin E2 (PGE2), primary mediators of inflammatory pain and vascular permeability. PBM additionally reduces pro-inflammatory cytokines TNF-α, IL-1β, and IL-6, while increasing the anti-inflammatory cytokine IL-10. Mast cell stabilisation further limits local inflammatory amplification (Hamblin, 2017).

• Pain Modulation: Beyond inflammation reduction, PBM directly modulates nociception by reducing expression of substance P, transient receptor potential vanilloid 1 (TRPV-1), and calcitonin gene-related peptide (CGRP) in peripheral sensory nerves, attenuating both peripheral sensitisation and the central sensitisation that commonly accompanies chronic musculoskeletal pain (Hamblin, 2017).

• Fibroblast Activation and Collagen Synthesis: PBM stimulates fibroblast proliferation and increases Type I and Type III collagen synthesis, supporting wound closure, tissue remodelling, and restoration of tensile strength in injured musculoskeletal structures.

• Growth Factor Upregulation: HPLT stimulates production of transforming growth factor-beta 1 (TGF-β1), insulin-like growth factor 1 (IGF-1), and fibroblast growth factor (FGF), key mediators of tissue repair, matrix remodelling, and angiogenesis.

The Pre-Operative Window: Priming Tissues for Surgery

The weeks before a scheduled orthopaedic procedure represent a critical and frequently underutilised opportunity to optimise the biological environment of tissues that will be surgically manipulated. Tissue entering surgery with richer vascularity, healthier extracellular matrix, greater cellular energy reserves, and lower inflammatory burden heals more efficiently, responds more reliably to suture and fixation, and supports more rapid post-operative rehabilitation. This principle underpins the growing prehabilitation movement (Punnoose et al., 2023).

Pre-Operative Shockwave Therapy

Tissue Vascularisation: Chronically injured tendons and degenerative joint tissues typically exhibit hypovascular zones, a consequence of repetitive mechanical load exceeding angiogenic repair capacity. Pre-operative ESWT stimulates VEGF and eNOS upregulation, driving neovascularisation in these ischaemic regions before surgical intervention. Improved vascularity provides richer delivery of oxygen, immune cells, and regenerative growth factors to the surgical site from the earliest moments of post-operative healing (Notarnicola & Moretti, 2012; Wang, 2012).

Collagen Quality: In chronically degenerate tendons, the rotator cuff, patellar tendon, or distal biceps, the extracellular matrix is characterised by disorganised Type III collagen, mucoid degeneration, and fibre discontinuity. Pre-operative ESWT stimulates tenocyte activity and Type I collagen synthesis, improving the structural integrity of tissue that will be sutured, anchored, or reconstructed. Better quality tissue provides more reliable purchase for sutures and fixation devices, and a more robust substrate for graft incorporation (Lo et al., 2022; Mani-Babu et al., 2015).

Periosteal and Bone Priming: For procedures involving bone tunnels (as in ACL and PCL reconstruction), osteotomy, or bony fixation, pre-operative ESWT may activate periosteal progenitor cells and upregulate osteogenic growth factors including BMP-2. This provides a more robust osteogenic environment to support bone healing at fixation sites and graft tunnel interfaces from the first days post-surgery (Wu et al., 2023).

Muscle Preservation: Satellite cell activation through pre-operative ESWT may increase the myogenic reserve of peri-articular muscles, the quadriceps before knee surgery, the rotator cuff musculature before shoulder surgery. A larger, primed pool of satellite cells may attenuate the profound post-operative muscle atrophy that follows surgical trauma and enforced immobilisation, potentially accelerating strength recovery during rehabilitation (PMC5889540, 2018).

Pre-Operative Inflammation Management: In conditions where surgery is planned following failed conservative management, such as calcific rotator cuff tendinopathy, pre-operative ESWT can reduce calcium deposit burden and local inflammatory load, potentially reducing intraoperative tissue friability and the magnitude of the post-operative inflammatory response. A 2024 systematic review with meta-analysis confirmed ESWT efficacy for calcific rotator cuff tendinopathy across multiple clinical outcomes (Brindisino et al., 2024).

Pre-Operative High-Power Laser Therapy

Mitochondrial Priming: By reversing NO-mediated CcO inhibition and restoring ATP production capacity in chronically inflamed or degenerative tissues before surgery, HPLT may enhance the metabolic resilience of peri-surgical structures to the acute physiological insult of operative tissue trauma. Tissues with restored mitochondrial function are better equipped to mount efficient and timely healing responses from the moment post-surgical repair begins (Hamblin, 2018).

Inflammatory Resolution: HPLT reduces chronic inflammatory mediators, COX-2, PGE2, TNF-α, IL-6, in tissues scheduled for surgical intervention. Lowering the pre-existing inflammatory burden before surgery may reduce the magnitude of the post-operative inflammatory surge and create a more favourable biochemical environment for early healing (Hamblin, 2017).

Collagen and Matrix Optimisation: Fibroblast stimulation through pre-operative HPLT improves collagen quality and fibre organisation in chronically injured tendons and ligaments, providing a more architecturally sound tissue substrate for surgical repair and reconstruction.

Neural Sensitisation Attenuation: Chronic pain associated with orthopaedic surgical pathology is frequently accompanied by peripheral and central sensitisation, a lowered nociceptive threshold that amplifies post-operative pain. Pre-operative PBM-mediated reduction of substance P, CGRP, and TRPV-1 may attenuate this sensitised neural state, contributing to improved post-operative pain profiles and reduced analgesic requirements (Hamblin, 2017).

Oedema Management: HPLT reduces tissue oedema through modulation of vascular permeability and enhancement of lymphatic function, particularly beneficial in joints with pre-existing effusion or chronic swelling prior to scheduled surgery. Reduced pre-operative oedema may improve tissue mobility and surgical access.

Post-Operative Recovery: Accelerating the Healing Cascade

The post-operative period places extraordinary demands on biological healing systems. Acute inflammation, pain, oedema, muscle atrophy, impaired tissue perfusion, and the challenge of remodelling surgically repaired structures to their native mechanical properties must all be addressed within recovery timelines that are often frustratingly prolonged. Both ESWT and HPLT directly target the key biological constraints on this process.

Post-Operative Shockwave Therapy

Post-operative ESWT is typically introduced once incisional healing has occurred, generally from four to eight weeks post-surgery depending on the procedure and individual healing trajectory. ESWT should not be applied directly over open wounds, surgical staples, or in close proximity to superficially positioned metallic hardware.

ACL Reconstruction: Two 2025 systematic reviews have evaluated ESWT as an adjunct to post-ACL rehabilitation. A meta-analysis in BMC Musculoskeletal Disorders identified six studies (five RCTs) and demonstrated that ESWT combined with standard rehabilitation improved Lysholm knee scores compared to rehabilitation alone (weighted mean difference: 3.72), with focused ESWT showing particular promise for graft maturation and functional recovery (Zhang et al., 2025a). A concurrent meta-analysis in the World Journal of Orthopaedics similarly identified functional benefits for ESWT adjuncts in ACL reconstruction rehabilitation (Zhang et al., 2025b). The proposed biological mechanism centres on ESWT-stimulated angiogenesis at the tendon-to-bone tunnel interface, BMP-2 upregulation supporting osseointegration of the graft within the bone tunnel, and satellite cell activation to mitigate post-operative quadriceps atrophy.

Insertional Achilles Tendon Surgery: A 2025 case-control pilot study found that perioperative ESWT and radial pressure wave therapy may improve post-operative outcomes following insertional Achilles tendon surgeries — a procedure with average recovery timelines of seven months to return to physical activity (Springer Nature, 2025). Earlier application of angiogenic and collagen-stimulating shockwave effects may help compress this extended timeline by supporting tendon healing at the calcaneal insertion.

Post-Operative Bone Healing: Following osteotomy, bone tunnelling, or fracture fixation, ESWT may accelerate bone consolidation through upregulation of BMP-2, osteocalcin, and VEGF; promotion of endochondral ossification; and activation of periosteal progenitor cells. Evidence from delayed and non-union fracture management demonstrates that ESWT can reactivate stalled bone healing cascades (Wu et al., 2023) biological mechanisms equally applicable to planned surgical bone trauma and graft tunnel integration.

Soft Tissue and Wound Healing: A 2025 preclinical study confirmed that ESWT accelerates soft tissue wound healing through enhanced angiogenesis, growth factor release, and fibroblast activation (PMC12127221, 2025), supporting the post-surgical application of shockwave energy to surgical soft tissue healing contexts once primary wound closure has been achieved.

Post-Operative High-Power Laser Therapy

A key advantage of HPLT in the post-operative setting is its suitability for early application. Because it is non-contact and exerts its effects through photon absorption at the cellular level, HPLT can be commenced within days of surgery, once skin integrity has been confirmed, making it a uniquely valuable early-phase intervention when ESWT is not yet appropriate.

Total Knee Arthroplasty (TKA): Two randomised controlled trials have demonstrated meaningful post-operative benefits of laser therapy following TKA. Bahrami et al. (2022) conducted a three-arm RCT comparing LLLT (804 nm), Bioptron light, and standard care following TKA. The LLLT group demonstrated significantly superior knee range of motion at all follow-up intervals to three months (116.8° versus 92.3° in controls; P < .001), reduced knee swelling, lower opioid (oxycodone) consumption, and improved Knee Society Scores. Chia et al. (2025) subsequently confirmed that PBMT significantly reduces post-operative swelling in TKA patients, measured objectively via bioimpedance analysis, with associated enhancement of early rehabilitation participation.

Rotator Cuff Repair: Active RCTs are evaluating HPLT following arthroscopic rotator cuff repair (ClinicalTrials.gov NCT07568288), with protocols delivering 1000 J per session over 15 minutes to the shoulder region. Existing evidence from tendinopathy management supports PBM’s capacity to reduce inflammatory burden in repaired tendon tissue while stimulating organised collagen synthesis during the critical early healing window, a period in which the repaired tendon is particularly vulnerable to inflammatory disruption and fibrotic scarring.

Postoperative Tissue Healing, Systematic Review Evidence: A 2025 systematic review of 14 RCTs examining laser-based PBM in postoperative tissue healing found that PBMT consistently improved early soft tissue healing, reduced postoperative inflammation and oedema, and in selected cases accelerated bone remodelling (Dabić et al., 2025). This broad efficacy profile reflects PBMT’s multi-target mechanism, which simultaneously addresses the key biological barriers to early post-operative recovery.

Pain Management and Opioid Reduction: The analgesic effects of HPLT, through COX-2 inhibition, PGE2 reduction, and nociceptive fibre modulation, provide a meaningful non-pharmacological contribution to post-operative pain management. Reduced post-operative pain facilitates earlier and more effective physiotherapy engagement, itself a primary driver of functional recovery. The demonstrated reduction in opioid consumption following TKA (Bahrami et al., 2022) highlights the potential of HPLT to contribute to post-surgical opioid stewardship.

A Synergistic Approach: Combining Shockwave and Laser Therapy

ESWT and HPLT engage distinct but complementary biological mechanisms, making their combination particularly compelling as a perioperative strategy. Rather than competing for the same cellular targets, they address different aspects of the healing cascade in a manner that is additive across the recovery timeline.

In the pre-operative phase, ESWT drives angiogenesis, collagen remodelling, bone priming, and satellite cell activation, while HPLT addresses mitochondrial function, chronic inflammation, neural sensitisation, and matrix quality, together creating a more comprehensively optimised biological substrate for surgery.

In the post-operative phase, HPLT’s suitability for early application (days post-surgery) means it can manage the acute inflammatory and pain burden before the tissue has consolidated sufficiently to tolerate ESWT, which is introduced at four to eight weeks to drive tissue remodelling, bone healing, and myogenic recovery. This sequential and complementary deployment covers the full biological spectrum of surgical recovery: from acute inflammation resolution and pain management in the early weeks, through progressive tissue remodelling, bone consolidation, and muscle regeneration across the mid-to-late rehabilitation period.

Who May Benefit?

Patients most likely to benefit from perioperative shockwave and laser therapy include those undergoing:

• Anterior cruciate ligament (ACL) and posterior cruciate ligament (PCL) reconstruction

• Rotator cuff repair (arthroscopic or open)

• Total knee arthroplasty (TKA) and total hip arthroplasty (THA)

• Insertional Achilles tendon surgery and Achilles tendon reconstruction

• Lateral ankle ligament repair and stabilisation

• Tibial, femoral, or calcaneal osteotomy

• Open reduction and internal fixation (ORIF) for fracture management

• Patellar or quadriceps tendon repair

• Spinal surgery requiring peri-articular musculature support and recover

Patients with pre-operative chronic pain, poor tissue quality on imaging, elevated inflammatory markers, or significant peri-articular muscle weakness represent particularly strong candidates for pre-operative intervention. Post-operative candidates include any individual where accelerated tissue healing, pain reduction, oedema management, or earlier return to active rehabilitation is a clinical priority.

A thorough individual assessment by a qualified physiotherapist is essential prior to commencing any perioperative modality programme. Treatment protocols are always individualised to the specific surgical procedure, healing stage, tissue response, and rehabilitation goals.

Safety Considerations

Both modalities carry excellent safety profiles when administered by appropriately trained clinicians.

For EMS DolorClast® Shockwave Therapy, absolute contraindications include active blood coagulation disorders or anticoagulant therapy, active malignancy within the intended treatment area, pregnancy, and active local infection. Caution is exercised with application in close proximity to implanted electronic devices (cardiac pacemakers, spinal cord stimulators) and over superficially positioned metallic fixation hardware. Application over open epiphyseal growth plates in skeletally immature patients is avoided. The most common adverse effect is transient local soreness in the 24–48 hours following treatment.

For High-Power Laser Therapy, certified laser safety goggles are mandatory for both the treating clinician and the patient during all treatment sessions. HPLT is contraindicated over active malignancy within the treatment field, and caution is warranted in patients taking photosensitising medications. Direct application over unhealed surgical wounds is avoided until skin integrity is confirmed. Both modalities are associated with no known systemic adverse effects at therapeutic parameters.

Conclusion: Evidence-Informed, Biologically Grounded Perioperative Care

The convergence of mechanobiological and photobiomodulatory science provides a compelling rationale for integrating EMS DolorClast® Shockwave Therapy and High-Power Laser Therapy into perioperative orthopaedic care. Pre-operatively, these modalities prime surgical tissues through angiogenesis, collagen remodelling, mitochondrial optimisation, and inflammatory resolution, providing both the operating surgeon and the patient with a superior biological starting point. Post-operatively, they accelerate the healing cascade across its multiple phases: from acute inflammation resolution and pain modulation in the first days and weeks, through tissue remodelling, bone consolidation, and muscle regeneration across the months of rehabilitation.

Critically, these treatment effects are grounded in well-characterised cellular and molecular mechanisms, mechanotransduction, angiogenesis, mitochondrial electron transport rescue, COX-2 inhibition, collagen synthesis, and satellite cell activation, documented across high-quality preclinical and clinical research. The growing body of randomised controlled trial and systematic review evidence, including positive outcomes for TKA rehabilitation (Bahrami et al., 2022; Chia et al., 2025) and ACL reconstruction recovery (Zhang et al., 2025a, 2025b), supports their clinical integration.

At Movement Mechanics, we combine these technologies within a comprehensive, individually tailored perioperative physiotherapy programme. If you are preparing for orthopaedic surgery, or navigating the challenges of post-operative recovery, we welcome the opportunity to discuss whether perioperative shockwave and laser therapy is right for your situation. Evidence-informed care begins well before the surgery suite, and extends well beyond it.

---

Jonathan Hall M.Ost, BAppSci (Human Biology), PGCertHSc (Acupuncture), GradDipHeal, FIFA Diploma in Football Medicine

Jonathan Hall is the founder and principal Osteopath at Movement Mechanics Osteopathy. Jonathan specialises in Shockwave Therapy and Western Medical Acupuncture and is a Key Opinion Leader for EMS Swiss DolorClast. A fully qualified Osteopath registered with OCNZ, PNZ, PAANZ and ACC, Jonathan also founded Auckland Shockwave Therapy to bring evidence-based shockwave treatment to New Zealand using the industry-leading EMS DolorClast® device.

Book an appointment with Jonathan here.

Contact Us: hello@movementmechanics.nz

References

Bahrami, M., Moharrami, A., Ghaffari, A., Ebrahimzadeh, M. H., & Birjandinejad, A. (2022). Low-level laser and light therapy after total knee arthroplasty improves postoperative pain and functional outcomes: A three-arm randomized clinical trial. Arthroplasty Today, 19, 101087. https://doi.org/10.1016/j.artd.2022.101087

Brindisino, F., Lorusso, M., Anastasio, A., & Giordano, A. (2024). The effectiveness of extracorporeal shock wave therapy for rotator cuff calcific tendinopathy: A systematic review with meta-analysis. Physiotherapy Research International, 29(1), e2106. https://doi.org/10.1002/pri.2106

Chia, W.-T., Wong, T.-H., Jaw, F.-S., & Hsieh, H.-C. (2025). The impact of photobiomodulation therapy on swelling reduction and recovery enhancement in total knee arthroplasty: A randomized clinical trial. Photobiomodulation, Photomedicine, and Laser Surgery. https://doi.org/10.1089/photob.2024.0120

Dabić, M., Plavčić, M., Galić, I., Dabić, T., & Bago, I. (2025). Laser-based photobiomodulation in postoperative tissue healing in oral and maxillofacial surgery: Systematic review of RCTs. Journal of Clinical Medicine, 15(2), 613. https://doi.org/10.3390/jcm15020613

EMS Electro Medical Systems. (2024). DolorClast® radial shock waves: Clinical evidence and device performance. EMS Pain Therapy. https://www.ems-dolorclast.com/dolorclastr-radial-shock-waves

Hamblin, M. R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361. https://doi.org/10.3934/biophy.2017.3.337

Hamblin, M. R. (2018). Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochemistry and Photobiology, 94(2), 199–212. https://doi.org/10.1111/php.12864

Lo, W. C., Chiou, J. F., Fang, W., & Tsai, A. I. (2022). Biological response of extracorporeal shock wave therapy to tendinopathy in vivo: A review. Frontiers in Veterinary Science, 9, 851894. https://doi.org/10.3389/fvets.2022.851894

Mani-Babu, S., Morrissey, D., Waugh, C., Screen, H., & Barton, C. (2015). The effectiveness of extracorporeal shock wave therapy in lower limb tendinopathy: A systematic review. American Journal of Sports Medicine, 43(3), 752–761. https://doi.org/10.1177/0363546514531801

Notarnicola, A., & Moretti, B. (2012). The biological effects of extracorporeal shock wave therapy (ESWT) on tendon tissue. Muscles, Ligaments and Tendons Journal, 2(1), 33–37.

PMC5889540. (2018). Exposure to radial extracorporeal shock waves modulates viability and gene expression of human skeletal muscle cells: A controlled in vitro study. National Library of Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5889540/

PMC12127221. (2025). Effects of extracorporeal shockwave therapy on wound healing. National Library of Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12127221/

Punnoose, A., Claydon-Mueller, L. S., Weiss, O., Zhang, J., Rushton, A., & Khanduja, V. (2023). Prehabilitation for patients undergoing orthopedic surgery: A systematic review and meta-analysis. JAMA Network Open, 6(4), e238050. https://doi.org/10.1001/jamanetworkopen.2023.8050

Springer Nature. (2025). Extracorporeal shock wave therapy (ESWT) and radial pressure waves (RPW) may improve post-operative recovery following insertional Achilles tendon surgeries: A case-control pilot study. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/s13018-025-06165-5

Wang, C. J. (2012). Extracorporeal shockwave therapy in musculoskeletal disorders. Journal of Orthopaedic Surgery and Research, 7, Article 11. https://doi.org/10.1186/1749-799X-7-11

Wu, Y., Cao, Z., Li, Y., Song, J., Chen, X., & Zhang, Y. (2023). The effects and underlying mechanism of extracorporeal shockwave therapy on fracture healing. Frontiers in Endocrinology, 14, 1188297. https://doi.org/10.3389/fendo.2023.1188297

Zhang, K., Wu, H., Li, M., & Chen, J. (2025a). Use of extracorporeal shockwave therapy combined with standard rehabilitation following anterior cruciate ligament reconstruction: A systematic review with meta-analysis. BMC Musculoskeletal Disorders. https://doi.org/10.1186/s12891-025-08277-9

Zhang, L., Wang, X., Liu, Y., & Zhao, H. (2025b). Evaluating the efficacy of extracorporeal shockwave therapy in postoperative rehabilitation after anterior cruciate ligament reconstruction: A meta-analysis. World Journal of Orthopaedics, 16, 110324. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12754467/

 Disclaimer: This content is for educational purposes and does not constitute medical advice. Individual patient suitability for perioperative shockwave and laser therapy should be assessed by a qualified healthcare practitioner in direct collaboration with the treating surgical team. Contraindications to ESWT and photobiomodulation must be screened for prior to treatment.